Gender differences in the risk of familial parkinsonism: Beyond LRRK2?

Neuroscience Letters

Volumn 496, Issue 2, 2011, Pages 125-128

  Saunders Pullman, R ^a,b   Stanley, K ^a   Luciano, M San ^a   Barrett, M J ^a   Shanker, V ^a,b   Raymond, D ^a   Ozelius, L J ^c   Bressman, S B ^a,b  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Family history; Gender; Genetic; Jewish; LRRK2; Parkinson disease; Women

Indexed keywords

GLUCOSYLCERAMIDASE; LEUCINE RICH REPEAT KINASE 2;

AGED; ARTICLE; DISEASE PREDISPOSITION; FAMILY HISTORY; FEMALE; GENE MUTATION; HIGH RISK POPULATION; HUMAN; JEW; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SEX DIFFERENCE;

AGED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; JEWS; MALE; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION;

EID: 79955720303     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.03.098     Document Type: Article

References (33)

1. Baba Y., Putzke J.D., Whaley N.R., Wszolek Z.K., Uitti R.J. Gender and the Parkinson's disease phenotype. J. Neurol. 2005, 252:1201-1205.
2. Baldereschi M, DiCarlo A, Rocca WA, Vanni P, Maggi S, Perissinotto E, Grigoletto F, Amaducci L, Inzitari D. ILSA Working Group, Italian Longitudinal Study on Aging, Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. Neurology 15 (2000), 1358-1363.
3. Bonifati V., Fabrizio E., Vanacore N., De Mari M., Meco G. Familial Parkinson's disease: a clinical genetic analysis. Can. J. Neurol. Sci. 1995, 22:272-279.
4. Bower J.H., Maraganore D.M., McConnell S.K., Rocca W.A. Incidence and distribution of parkinsonism in Olmsted County, Minnesota 1976-1990. Neurology 1999, 52:1214-1220.
5. De Michele G., Filla A., Volpe G., De Marco V., Gogliettino A., Ambrosio G., Marconi R., Castellano A.E., Campanella G. Environmental and genetic risk factors in Parkinson's disease: a case-control study in southern Italy. Mov. Disord. 1996, 11:17-23.
6. Elbaz A., McDonnell S.K., Maraganore D.M., Strain K.J., Schaid D.J., Bower J.H., Ahlskog J.E., Rocca W.A. Validity of family history data on PD: evidence for a family information bias. Neurology 2003, 61:11-17.
7. Elbaz A., Grigoletto F., Baldereschi M., Breteler M.M., Manubens-Bertran J.M., Lopez-Pousa S., Dartigues J.F., Alperovitch A., Tzourio C., Rocca W.A. Familial aggregation of Parkinson's disease: a population-based case-control study in Europe. Europarkinson Study Group. Neurology 1999, 52:1876-1882.
8. Gan-Or Z., Bar-Shira A., Mirelman A., Gurevich T., Kedmi M., Giladi N., Orr-Urtreger A. LRRK2 and GBA mutations differentially affect the initial presentation of Parkinson disease. Neurogenetics 2010, 11:121-125.
9. Gillies G.E., McArthur S. Independent influence of sex steroids of systemic and central origin in a rat model of Parkinson's disease: a contribution to sex-specific neuroprotection by estrogen. Horm. Behav. 2010, 57:23-34.
10. Kasten M., Kertelge L., Brueggemann, van der Vegt J., Schmidt A., Tadic V., Buhmann C., Steinlechner S., Behrens M.I., Ramirez A., Binkofski F., Siebner H., Raspe H., Hagenah J., Lencer R., Klein C. Nonmotor symptoms in genetic Parkinson disease. Arch. Neurol. 2010, 67:670-676.
11. Kay D.M., Higgins D., Zabetian C.D., Payami H. Escaping Parkinson's disease: a neurologically healthy octogenarian with the LRRK2 G2019S mutation. Mov. Disord. 2005, 20:1077-1078.
12. Kuopio A., Marttila R.J., Helenius H., Rinne U.K. Familial occurrence of Parkinson's disease in a community-based case-control study. Parkinsonism Relat. Disord. 2001, 7:297-303.
13. Latourelle J.C., Sun M., Lew MF, Suchowersky O., Klein C., Golbe L.I., Mark M.H., Growdon J.H., Wooten G.F., Watts R.L., Guttman M., Racette B.A., Perlmutter J.S., Ahmed A., Shill H.A., Singer C., Goldwurm S., Pezzoli G., Zini M., Saint-Hilaire M.H., Hendricks A.E., Williamson S., Nagle M.W., Wilk J.B., Massood T., Huskey K.W., Laramie J.M., DeStefano A.L., Baker K.B., Itin I., Litvan I., Nicholson G., Corbett A., Nance M., Drasby E., Isaacson S., Burn D.J., Chinnery P.F., Pramstaller P.P., Al-hinti J., Moller A.T., Ostergaard K., Sherman S.J., Roxburgh R., Snow B., Slevin J.T., Cambi F., Gusella J.F., Myers R.H. The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD Study. BMC Med. 2008, 6:32.
14. Marder K., Tang M., Mejia H., Alfaro B., Côté L., Louis E., Groves J., Mayeux R. Risk of Parkinson's disease among first-degree relatives: a community-based study. Neurology 1996, 47:155-160.
15. Marder K., Levy G., Louis E.D., Mejia-Santana H., Cote L., Andrews H., Harris J., Waters C., Ford B., Frucht S., Fahn S., Ottman R. Accuracy of family history data on Parkinson's disease. Neurology 2003, 61:18-23.
16. Nishioka K., Kefi M., Jasinska-Myga B., Vilariño-Güell C., Ross O.A., Heckman M.G., Middleton L.T., Ishihara-Paul L., Gibson R.A., Amouri R., Ben Yahmed S., Ben Sassi S., Zouari M., El Euch G., Farrer M.J., Hentati F. A comparative study of LRRK2 PINK1 and genetically undefined familial Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 2010, 81:391-395.
17. Orr-Urtreger A, Shifrin C., Rozovski U., Rosner S., Bercovich D., Gurevich T., Yagev-More H., Bar-Shira A., Giladi N. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?. Neurology 2007, 69:1595-1602.
18. Ozelius L.J., Senthil G., Saunders-Pullman R., Ohmann E., Deligtisch A., Tagliati M., Hunt A.L., Klein C., Henick B., Hailpern S.M., Lipton R.B., Soto-Valencia J., Risch N., Bressman S.B. LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N. Engl. J. Med. 2006, 354:424-425.
19. Pankratz N, Nichols WC, Uniacke SK, Halter C, Rudolph A, Shults C, Conneally PM, Foroud T. Parkinson Study Group, Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations, Am J Hum Genet, 71 (2002), 124-135.
20. Rocca W., Bower J.H., Maraganore D.M., Ahlskog J.E., Grossardt B.R., de Andrade M., Melton L.J.3rd Increased risk of parkinsonism in women who underwent oophorectomy before menopause. Neurology 2008, 70:200-209.
21. Rocca W.A., Peterson B.J., McDonnell S.K., Bower J.H., Ahlskog J.E., Schaid D.J., Maraganore D.M. The Mayo clinic family study of Parkinson's disease: study design, instruments, and sample characteristics. Neuroepidemiology 2005, 24:151-167.
22. Ruiz-Martínez J., Gorostidi A., Ibenez, Alzualde A., Otaegui D., Moreno F., López de Munain A., Bergareche A., Gómez-Esteban J.C., Massó J.F. Penetrance in Parkinson's disease related to the LRRK2 R1441G mutation in the Basque country (Spain). Mov. Disord. 2010, 25:2340-2345.
23. Rybicki B.A., Johnson C.C., Peterson E.L., Kortsha G.X., Gorell J.M. A family history of Parkinson's disease and its effect on other PD risk factors. Neuroepidemiology 1999, 18:270-278.
24. San Luciano M., Lipton R.B., Wang C., Katz M., Zimmerman M.E., Sanders A.E., Ozelius L.J., Bressman S.B., Saunders-Pullman R. Clinical expression of LRRK2 G2019S mutations in the elderly. Mov. Disord. 2010, 25:2571-2576.
25. Saunders-Pullman R. Estrogens and Parkinson disease: neuroprotective, symptomatic, neither, or both?. Endocrine 2003, 21:81-87.
26. Saunders-Pullman R., Lipton R.B., Senthil G., Katz M., Costan-Toth C., Derby C., Bressman S., Verghese J., Ozelius L.J. Increased frequency of the LRRK2 G2019S mutation in an elderly Ashkenazi Jewish population is not associated with dementia. Neurosci. Lett. 2006, 402:92-96.
27. Sellbach A.N., Boyle R., Silburn P., Mellick G. Parkinson's disease and family history. Parkinsonism Relat. Disord. 2006, 12:399-409.
28. Simunovic F., Yi M., Wang Y., Stephens R., Sonntag K.C. Evidence for gender-specific transcriptional profiles of nigral dopamine neurons in Parkinson disease. PLoS One 2010, 5:e8856.
29. Taylor K.S.M., Cook J.A., Counsell C.E. Heterogeneity in male to female risk for Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 2007, 78:905-912.
30. Troiano AR, Elbaz A, Lohmann E, Belarbi S, Vidailhet M, Bonnet AM, Lesage S, Pollak P, Cazeneuve C, Borg M, Feingold J, Dürr A, Tazir M, Brice A. French Parkinson disease Genetic Study Group, Low disease risk in relatives of North African LRRK2 Parkinson disease patients, Neurology 75 (2010),1118-1119.
31. Uitti R.J., Shinotoh H., Hayward M., Schulzer M., Mak E., Calne D.B. Familial Parkinson's disease-a case-control study of families. Can. J. Neurol. Sci. 1997, 24:127-132.
32. Van Den Eeden S.K., Tanner C.M., Bernstein A.L., Fross R.D., Leimpeter A., Bloch D.A., Nelson L.M. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am. J. Epidemiol. 2003, 151:1015-1022.
33. Wooten G.F., Currie L.J., Bovbjerg V.E., Lee J.K., Patrie J. Are men at greater risk for Parkinson's disease than women?. J. Neurol. Neurosurg. Psychiatry 2004, 75:637-639.